INTRODUCTIONFemale sex is considered as one of the risk factors for worse outcomes in cardiac surgery as represented by increased mortality in the European System for Cardiac Operative Risk Evaluation II and Society of Thoracic Surgeons score. The outcomes of female vs. male in both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have been controversial. In one study, female patients received more blood transfusions and had significantly higher 30‐days mortality (3.7% vs. 2.2%) compared to male who underwent SAVR . Conversely, female patients had similar or even lower early (in‐hospital or 30‐days) mortality compared to male who underwent TAVR despite experiencing more vascular complication, bleeding and stroke compared to their male counterpart .Although outcomes of females vs. males in either TAVR or SAVR have been investigated, the comparative outcomes of TAVR vs. SAVR in large female population are limited. Female exhibit different perioperative complication pattern compared to male and therefore, the optimal modes of aortic valve replacement in female patients remain undetermined. To investigate therapeutic options between TAVR and SAVR in this specific cohort, we decided to investigate the clinical outcomes between TAVR and SAVR in female using the Nationwide Inpatient Sample (NIS) database.METHODSData sourceNIS
Catheterization and Cardiovascular Interventions – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera